Menu
Not yet recruiting NCT07568262

The Effectiveness of High-intensity Laser Therapy on Post-surgical Rehabilitation After Total Knee Arthroplasty

No phase Interventional Arthroplasty Complications Pain, Postoperative

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: High level laser therapy, Sham laser therapy.
Who it may be relevant to
Registry conditions: Arthroplasty Complications, Pain, Postoperative. Basic parameters: 50 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Italy
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

The Effectiveness of High-intensity Laser Therapy on Post-surgical Rehabilitation: a Randomized Controlled Trial

Overview

This randomized controlled trial aims to evaluate the effectiveness of high-intensity laser therapy (HILT) as an adjunct to conventional rehabilitation in patients undergoing total knee arthroplasty (TKA). Persistent pain and functional limitations are common after TKA despite standard rehabilitation, highlighting the need for adjunctive therapies to optimize postoperative recovery. High-intensity laser therapy has been proposed as a non-invasive intervention with potential analgesic and anti-inflammatory effects; however, its effectiveness in this population remains unclear. Participants will be randomly allocated to one of two groups: an experimental group receiving HILT in addition to conventional physiotherapy and a control group receiving sham laser therapy combined with the same rehabilitation program. Both groups will undergo standardized rehabilitation sessions lasting 60 minutes, including 15 minutes of active or sham laser therapy and 45 minutes of conventional physiotherapy. The primary outcome is postoperative pain. Secondary outcomes include joint swelling, range of motion, muscle strength, physical function, and quality of life. Assessments will be conducted at baseline (preoperative), at 1 month after surgery (prior to the start of rehabilitation), during the rehabilitation program (after the fourth, seventh, and tenth physiotherapy sessions), and at 4 months postoperatively (follow-up). A total of 46 participants (23 per group) will be enrolled in the study.

Interventions

  • Device High level laser therapy
    High-intensity laser therapy (HILT) will be delivered using the HIRO TT device (ASA S.r.l.), which employs a patented pulsed laser system (FDA-approved in 2003) based on a solid-state Nd:YAG source emitting near-infrared (NIR) radiation at a wavelength of 1064 nm. The device operates with a mean power of 10.5 W and a peak power of 3 kW. Three treatment areas (each measuring 15 × 10 cm) will be targeted: two longitudinal areas over the quadriceps muscle and one transverse area over the knee join
  • Other Sham laser therapy
    The sham laser intervention will be delivered using the same HIRO TT device and identical treatment procedures as the active HILT group. The same anatomical areas (two longitudinal areas over the quadriceps muscle and one transverse area over the knee joint) will be targeted, with identical session duration and positioning. During sham treatment, the device will remain switched on; however, no therapeutic laser emission will be delivered. This approach is intended to ensure participant blindin

Primary outcome measures

  • Visual Analogue Scale [Time frame: after 3 weeks]
Secondary outcome measures (5)
  • Visual Analogue Scale [Time frame: Baseline, after 1 week, after 2 weeks, after 4 months follow-up]
  • Range of Motion [Time frame: Baseline, after 1 week, after 2 weeks, after 3 weeks, after 4 months follow-up]
  • Swelling [Time frame: Baseline, after 1 week, after 2 weeks, after 3 weeks, after 4 months follow-up]
  • Lower limb muscle strength [Time frame: Baseline, after 1 week, after 2 weeks, after 3 weeks, after 4 months follow-up]
  • Western Ontario and McMaster Universities Osteoarthritis Index [Time frame: Baseline, after 1 week, after 2 weeks, after 3 weeks, after 4 months follow-up]

Eligibility criteria

Inclusion criteria

  • Patients undergoing primary unilateral total knee arthroplasty for primary knee osteoarthritis
  • Age between 50 and 80 years
  • Pain intensity greater than 30/100 on the Visual Analog Scale (VAS)
  • Ability and willingness to provide written informed consent

Exclusion criteria

  • Psychiatric disorders
  • Cognitive impairments
  • Previous major trauma or surgery involving the affected knee
  • Rheumatic diseases or fibromyalgia
  • Vascular diseases
  • Neoplastic diseases
  • Infectious diseases
  • Neurological disorders
  • Hemophilia or bleeding disorders
  • Current anticoagulant therapy
  • Presence of a pacemaker
  • History of epileptic seizures
  • Known hypersensitivity or contraindication to laser therapy
  • Suspected conditions in which tissue heating is contraindicated
  • Use of photosensitizing medications or known photosensitivity
  • Skin lesions or abrasions at the treatment site
  • Tattoos in the treatment area
  • Intra-articular steroid injections in the target knee within the previous 2-3 weeks
  • Recent significant trauma or injury
  • Use of anti-inflammatory or analgesic medications or other pain-relieving treatments (if not controlled or standardized)
  • Pregnancy or breastfeeding
  • Positive status for human immunodeficiency virus

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Italy · 1 center
  • IRCCS Istituto Ortopedico Rizzoli — Bologna

Identifiers

NCT: NCT07568262 · LASER_KNEE

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗